| 2.02 Data as of May 24 |  +0.005 / +0.25%Today’s Change | 1.32 Today|||52-Week Range 2.15 | +26.73% Year-to-Date |
| Previous close | 2.01 |
| Today’s open | 2.03 |
| Day’s range | 2.01 - 2.03 |
| Volume | 58,375 |
| Average volume (3 months) | 65,462 |
| Market cap | $62.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -22.22% |
| Earnings growth (this year) | +85.71% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -0.21% |
| P/E ratio | 50.4 |
| Price/Sales | 0.61 |
| Price/Book | 0.79 |
| Today’s change | Today’s % change | |
|---|---|---|
| BVXBovie Medical Corp | +0.17 | +5.25% |
| TSONTranS1 Inc | +0.23 | +12.04% |
| MRICMRI Interventions In... | 0.00 | 0.00% |
| MELAMELA Sciences Inc | -0.01 | -0.90% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $82.6M |
| Annual profit (last year) | $2.1M |
| Net profit margin | 2.59% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer M. Christine Jacobs |
Chief Financial Officer & Treasurer Francis J. Tarallo, CPA |
Corporate headquarters Buford, Georgia |
.
